References
- Larsen PR. Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982: 306(1): 23–32
- Wehmann RE, Nisula BC. Radioimmunoassay of human thyrotropin: analytical and clinical developments. CRC Crit Rev Clin Lab Sci 1984: 20(3): 243–83
- Bigot ST, Ridgway EC, Kourides IA, et al. Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 1978: 46(2): 317–25
- Petersen V, Hall R, Smith BF. A study of thyroid stimulating activity in human serum with the highly sensitive cytochemical bioassay. J Clin Endocrinol Metab 1975: 41[1]: 199–202
- Wehmann RE, Rubenstein HA, Nisula BC. A sensitive, convenient radioimmunoassay procedure which demonstrates that serum h TSH is suppressed below the normal range in thyrotoxic patients. Endocr Res Commun 1979: 6(3): 249–55
- Utiger RD. Radioimmunoassay of human plasma thyrotropin. J Clin Invest 1965: 44(Aug): 1277–86
- Hershman JM, Pittman JA Jr. Utility of the radioimmunoassay of serum thyrotrophin in man. Ann Intern Med 1971: 74(4): 481–90
- Mayberry WE, Gharib H. Bilstad JM, et al. Radioimmunoassay for human thyrotrophin: clinical value in patients with normal and abnormal thyroid function. Ann Intern Med 1971: 74(4): 471–80
- Ormston BJ, Cryer RJ, Garry R, et al. Thyrotropin-releasing hormone as a thyroid-function test. Lancet 1971: 2(714): 10–4
- Spencer CA. Clinical utility of sensitive TSH assays. Thyroid Today 1986: 9(Sep): 1–8
- Spencer CA. Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 1988: 63(12): 1214–22
- Hay ID. Immunometric thyrotropin assays: current roles and future directions. Mayo Clin Proc 1988: 63(12): 1230–3
- Fish LH, Schwartz HL, Cavanaugh J, et al. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: role of triiodothyronine in pituitary feedback in humans. N Engl J Med 1987: 316(13): 764–70
- Bell GM, Sawers JS, Forfar JC, et al. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endocrinol (Oxf) 1983: 18(5): 511–6
- Beckett GJ, Kellett HA, Gow SM, et al. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage. BMJ (Clin Res) 1985: 291(6493): 427–31
- Ross DS, Neer RM, Ridgway EC, et al. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 1987: 82(6): 1167–70
- Gharib H, James EM, Charboneau JW, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study. N Engl J Med 1987: 317(2): 70–5
- Ehrmann DA. Weinberg M, Sarne DH. Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch Intern Med 1989: 149(2): 369–72
- Busnardo B, Bui F, Girelli ME. Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of an optimal saturation regimen with thyroxine or triiodothyronine. J Endocrinol Invest 1983: 6(6): 455–61
- Toft AD, Irvine WJ, Hunter WM, et al. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 1311 therapy for thyrotoxicosis. J Clin Endocrinol Metab 1974: 39(3): 607–9